HYPD Stock Analysis: Buy, Sell, or Hold?
HYPD - Hyperion DeFi, Inc. Common Stock
$3.60
0.03 (0.84%)
▲
5d:
-13.88%
30d:
+10.09%
90d:
-13.04%
WAIT
LOW Confidence
Analysis Updated: May 8, 2026 12:00 AM ET
Earnings: May 18, 2026
8d
Get Alerted When HYPD Hits Your Target Price
Join 10,000+ traders who never miss a move
You're in! Check your email to confirm and set your target price.
100% Free
No spam, ever
Unsubscribe anytime
Interactive Price Chart (1 Month)
Loading chart...
Loading historical data...
Bottom Line:
⏸️ WAIT FOR STABILIZATION: HYPD is down 13.9% over the last 5 days. While fundamentals may be solid, catching a falling knife is risky. Wait for price to stabilize before entering.
⏸️ WAIT FOR STABILIZATION: HYPD is down 13.9% over the last 5 days. While fundamentals may be solid, catching a falling knife is risky. Wait for price to stabilize before entering.
Long-Term Wealth Forecast (2031)
Based on Analyst Consensus Growth & Historical Valuation
0% (Stagnation)
50% (Hyper Growth)
EST. PRICE IN 2031
$0.17
Based on -38.1% avg growth
INTRINSIC VALUE TODAY
$0.10
Trading above historical range
How this is calculated: We use a Growth Decay Model: starting with analyst consensus growth (adjusted above) and gradually slowing it down to a long-term terminal rate (4%) by Year 5. This provides a more realistic valuation than assuming constant hyper-growth. We then apply a 6.8x Exit PE.
In-depth Analysis How we analyze
Valuation Analysis: HYPD is currently trading at $3.60, which is considered slightly low relative to its 30-day fair value range of $3.35 to $4.24. The stock's valuation (Forward PE: 6.3) is in line with its historical norms (6.8). Remarkably, the market is currently pricing in an annual earnings decline of 2.5% over the next few years. This aligns with recent fundamental challenges.
Technical Outlook: Technically, HYPD is in a uptrend. Immediate support is located at $3.25, while resistance sits at $4.99.
Market Sentiment: The stock shows a mixed technical setup (40/100), with neutral trendline and momentum signals. Wall Street analysts see significant upside, with an average price target of $6.28 (+74.3%). Current signals suggest waiting for a better entry point before initiating new positions.
Technical Outlook: Technically, HYPD is in a uptrend. Immediate support is located at $3.25, while resistance sits at $4.99.
Market Sentiment: The stock shows a mixed technical setup (40/100), with neutral trendline and momentum signals. Wall Street analysts see significant upside, with an average price target of $6.28 (+74.3%). Current signals suggest waiting for a better entry point before initiating new positions.
Quick Decision Summary
Current Position
SLIGHTLY LOW
Historical Trading Range
$3.35 -
$4.24
Company Quality Score
49/100
(HOLD)
Volume Confirmation
HIGH
Confidence Score
79.5%
All Signals
- BULLISH: Price oversold vs 30-day range
- NEUTRAL: Mixed technical signals (40/100)
- BULLISH: High volume confirmation
- BULLISH: Trading 74.3% below Wall St target ($6.28)
- WARNING: Recommendation downgraded due to -13.9% 5-day decline - wait for stabilization
Trading Range Analysis
30-Day Trading Range
$3.35 -
$4.24
Current vs Trading Range
SLIGHTLY LOW
Support & Resistance Levels
Support Level
$3.25
Resistance Level
$4.99
Current Trend
Uptrend
Technical data as of
May 8, 2026
Fundamental Context
Forward P/E (Next Year Est.)
6.32
Wall Street Target
$6.28
(+74.3%)
Revenue Growth (YoY)
1666.4%
Valuation Discount vs History
-2.5% cheaper
PE vs Historical
6.3 vs 6.8
FAIR
Market-Implied Price Targets
If current PE multiple persists
Implied Growth (YoY):
-2.5%
(market-implied from PE analysis)
1-Year Target
$3.51
(-3%)
2-Year Target
$3.42
(-5%)
3-Year Target
$3.34
(-7%)
3-Yr Target (if PE normalizes)
(PE: 6→7)
$3.59
(0%)
3-Year Scenarios
Using analyst projected EPS growth
Bull:
(PE: 21.9, Growth: -80.1%)
$9.12
(+153%)
Base:
(SPY PE: 6.3, Growth: -80.1%)
$2.62
(-27%)
Bear:
(PE: 5.4, Growth: -80.1%)
$2.23
(-38%)
💡
Upside Surprise Potential
If earnings stabilize (0% growth), PE could expand from 6.3 to 6.8
Stabilization Target:
$3.88
(+7.7%)
PE Expansion Potential:
+7.7%
Share & Embed Analysis
Last updated: May 08, 2026 7:03 PM ET
Data refreshes hourly during market hours. Next update: 8:03 PM
Data refreshes hourly during market hours. Next update: 8:03 PM
🔥 Top Stocks Breaking Out Now
| Ticker | Score | Recommendation | Change % |
|---|
Technical Signals Check
Is HYPD showing a specific setup today?
Insider Activity (6 Months)
9
Buys
0
Sells
+
Net
INSIDERS BUYING
Recent Transactions
David R Knox
BUY
27950 shares
2025-12-31
Ellen R Strahlman
BUY
12112 shares
2025-12-29
Ellen R Strahlman
BUY
11856 shares
2025-12-29
Top Rated Biotechnology Stocks
Top-rated stocks in Biotechnology by analyst ratings.
| Stock | Analyst Consensus | Analyst Target | Tradestie Score |
|---|---|---|---|
|
BMRN
Biomarin Pharmaceutical … |
STRONG BUY
29 analysts |
$90 | 57 HOLD |
|
CYTK
Cytokinetics Inc |
STRONG BUY
21 analysts |
$93 | 61 BUY |
|
BHVN
Biohaven Pharmaceutical … |
STRONG BUY
16 analysts |
$22 | 56 HOLD |
|
RVMD
Revolution Medicines Inc |
STRONG BUY
12 analysts |
$174 | 63 BUY |
|
VYGR
Voyager Therapeutics Inc |
STRONG BUY
12 analysts |
$15 | 58 HOLD |
